Biotech | November 12, 2021
Ronapreve gets the green light from CHMP to treat non-hospitalised Covid-19 patients
A final decision regarding the approval of Ronapreve is expected from the European Commission shortly
A final decision regarding the approval of Ronapreve is expected from the European Commission shortly
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
The company has operations in North America, Asia, and Europe,
Biocon Biologics and Viatris co-developed the products
Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
Gini Health works in the domain of personalised healthcare
The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population
Dr Lal PathLabs revenue contribution from west India to go up from 10% to 24% post-acquisition basis FY21
It is the first company to launch Remogliflozin, Vildagliptin and Metformin combination
The platform has seen an overall growth of 84% in the number of people seeking consultations for skin-related issues
Subscribe To Our Newsletter & Stay Updated
